Barclays analyst Theresa Chen maintains Phillips 66 (NYSE:PSX) with a Overweight and raises the price target from $95 to $113.
Minerva Neurosciences Announces $20M In Private Placement Priced At A Premium To Market
Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that it has agreed to
